These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31167067)

  • 21. Side effects and management of side effects of methotrexate in rheumatoid arthritis.
    Albrecht K; Müller-Ladner U
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S95-101. PubMed ID: 21044440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimising low-dose methotrexate for rheumatoid arthritis-A review.
    Lucas CJ; Dimmitt SB; Martin JH
    Br J Clin Pharmacol; 2019 Oct; 85(10):2228-2234. PubMed ID: 31276602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Rheumatoid arthritis: what to do if methotrexate fails?].
    Oberpichler-Schwenk H
    Med Monatsschr Pharm; 2013 Aug; 36(8):279. PubMed ID: 23977727
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of Tripterygium wilfordii Hook F with methotrexate in the treatment of rheumatoid arthritis.
    Marcus DM
    Ann Rheum Dis; 2014 Sep; 73(9):e56. PubMed ID: 24938284
    [No Abstract]   [Full Text] [Related]  

  • 25. Rheumatoid nodules developing under methotrexate treatment for rheumatoid arthritis.
    Duong TN; Blume-Peytavi U; Krengel S; Zouboulis CC; Orfanos CE
    Acta Derm Venereol; 1999 Sep; 79(5):397-8. PubMed ID: 10494728
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment of rheumatoid arthritis: 200 recommendations on the use of methotrexate].
    Durand S
    Perspect Infirm; 2009; 6(3):33-4. PubMed ID: 20120318
    [No Abstract]   [Full Text] [Related]  

  • 27. The facts about methotrexate in rheumatoid arthritis.
    Bannwarth B; Vernhes JP; Schaeverbeke T; Dehais J
    Rev Rhum Engl Ed; 1995; 62(7-8):471-3. PubMed ID: 8574608
    [No Abstract]   [Full Text] [Related]  

  • 28. Accelerated cutaneous nodulosis during methotrexate therapy in a patient with rheumatoid arthritis.
    Williams FM; Cohen PR; Arnett FC
    J Am Acad Dermatol; 1998 Aug; 39(2 Pt 2):359-62. PubMed ID: 9703153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A preliminary investigation of cognitive function in rheumatoid arthritis patients on long-term methotrexate treatment.
    Meade T; Cumming S; Hallab L; Spencer D; Howe G; Manolios N
    J Health Psychol; 2013 Oct; 18(10):1353-9. PubMed ID: 23188915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Call to Systematically Monitor for Adverse Events in Users of Low-Dose Methotrexate Therapy.
    Bykerk VP
    Ann Intern Med; 2020 Mar; 172(6):425-426. PubMed ID: 32066142
    [No Abstract]   [Full Text] [Related]  

  • 31. The safety of weekly low dose oral methotrexate in an Oriental population with rheumatoid arthritis.
    Thumboo J; Koh WH; Leong KH; Boey ML; Feng PH
    Ann Acad Med Singap; 1997 Mar; 26(2):205-9. PubMed ID: 9208075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discussion of Methotrexate Dosage.
    Maguire SA; Sheehy CM
    Ann Rheum Dis; 2018 Aug; 77(8):e47. PubMed ID: 28939632
    [No Abstract]   [Full Text] [Related]  

  • 33. Cyclosporine and methotrexate for severe rheumatoid arthritis.
    Malleson P
    N Engl J Med; 1995 Dec; 333(23):1567; author reply 1568-9. PubMed ID: 7477177
    [No Abstract]   [Full Text] [Related]  

  • 34. Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial.
    van Vollenhoven RF; Ernestam S; Geborek P; Petersson IF; Cöster L; Waltbrand E; Zickert A; Theander J; Thörner A; Hellström H; Teleman A; Dackhammar C; Akre F; Forslind K; Ljung L; Oding R; Chatzidionysiou A; Wörnert M; Bratt J
    Lancet; 2009 Aug; 374(9688):459-66. PubMed ID: 19665644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adverse events in methotrexate-treated rheumatoid arthritis patients.
    Sandoval DM; Alarcón GS; Morgan SL
    Br J Rheumatol; 1995 Nov; 34 Suppl 2():49-56. PubMed ID: 8535650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of amyloidosis secondary to rheumatoid arthritis with methotrexate].
    Fiter J; Nolla JM; Gómez Vaquero C; Valverde J
    Med Clin (Barc); 2000 Mar; 114(11):439. PubMed ID: 10786366
    [No Abstract]   [Full Text] [Related]  

  • 37. [Subcutaneous self-administration of methotrexate in rheumatoid arthritis].
    Huisman AM; Schouten JP; van Paassen HC; Wouters JM; Jacobs JW
    Ned Tijdschr Geneeskd; 1996 Jul; 140(30):1564-5. PubMed ID: 8765767
    [No Abstract]   [Full Text] [Related]  

  • 38. Cutaneous necrotizing vasculitis after low dose methotrexate therapy for rheumatoid arthritis: a possible manifestation of methotrexate hypersensitivity.
    Simonart T; Durez P; Margaux J; Van Geertruyden J; Goldschmidt D; Parent D
    Clin Rheumatol; 1997 Nov; 16(6):623-5. PubMed ID: 9456017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complications with low dose methotrexate in rheumatoid arthritis.
    Kalke S; Balakrishnan C; Mittal G; Mangat G; Joshi VR
    J Assoc Physicians India; 1997 Nov; 45(11):903-4. PubMed ID: 11229210
    [No Abstract]   [Full Text] [Related]  

  • 40. Nodulosis during methotrexate therapy for rheumatoid arthritis.
    Das SK; Kumar A
    J Assoc Physicians India; 1995 Sep; 43(9):651. PubMed ID: 8773077
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.